{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:30:46Z","timestamp":1792794646370,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pancreatic Cancer Research Fund, Cancer Research UK","award":["TRANSPAN CA2116"],"award-info":[{"award-number":["TRANSPAN CA2116"]}],"id":[{"id":"https:\/\/ror.org\/054225q67","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>NAD(P)H quinone dehydrogenase 1 (NQO1), a detoxification enzyme regulated by the Nrf2 cytoprotective pathway, is overexpressed in pancreatic ductal adenocarcinoma (PDAC). NQO1 levels are also influenced by the C609T single-nucleotide polymorphism (SNP). We hypothesized that elevated NQO1 would confer chemoresistance in PDAC and predict poor patient outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NQO1 tumor levels and germline C609T SNP status were assessed in archival samples from the European Study Group for Pancreatic Cancer (ESPAC) trials. NQO1 expression (H-score) was treated as continuous for survival regression analyses and dichotomized for visual summaries. Nrf2 or downstream gene induction was assessed in Nrf2 reporter mice or in PDAC cells following exposure to gemcitabine (Gem), 5-fluorouracil (5-FU), or the capecitabine (Cap) metabolite 5-fluoro-5\u2032-deoxyuridine (5\u2019-DFUR). Colony formation following NQO1 depletion was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NQO1 tumor levels correlated with germline C609T SNP status (P\u2009&amp;lt;\u2009.001). Contrary to our hypothesis, high NQO1 expression was associated with improved survival in ESPAC-4 patients randomized to GemCap (HR = 0.87 [95% CI = 0.751 to 0.999]; P\u2009=\u2009.049), and had no association to outcome in the Gem-only treated arm (HR = 0.98 [95% CI = 0.78 to 1.23]; P\u2009=\u2009.867). Including genotype data did not improve predictive model performance. Neither Gem nor 5-FU induced Nrf2 in vivo. At high concentrations, they suppressed Nrf2\/NQO1 in PDAC cells, an effect not mitigated by co-treatment with 5\u2019-DFUR. NQO1 depletion experiments revealed that NQO1 inhibits colony formation. The strongest inhibition was observed when NQO1-positive cells were co-treated with Gem and 5\u2019-DFUR, supporting our clinical data from ESPAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High tumor NQO1 predicts better outcome following GemCap therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaf345","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:11:25Z","timestamp":1764162685000},"page":"643-654","source":"Crossref","is-referenced-by-count":2,"title":["NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8672-9818","authenticated-orcid":false,"given":"Dylan","family":"Williams","sequence":"first","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]},{"name":"Faculty of Health Social Care & Medicine, Edge Hill University , Ormskirk,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-3420","authenticated-orcid":false,"given":"Chandni","family":"Patel","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9088-6595","authenticated-orcid":false,"given":"Kate","family":"Murray","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-402X","authenticated-orcid":false,"given":"Lucy","family":"Oldfield","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-2150","authenticated-orcid":false,"given":"Benjamin","family":"Small","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1908-162X","authenticated-orcid":false,"given":"Lawrence N","family":"Barrera","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7755-9888","authenticated-orcid":false,"given":"Rachel","family":"O\u2019Sullivan","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Birch-Ford","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-1730","authenticated-orcid":false,"given":"Anthony","family":"Evans","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Campbell","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-5136","authenticated-orcid":false,"given":"Pedro A","family":"Perez-Mancera","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-4178","authenticated-orcid":false,"given":"Christopher M","family":"Halloran","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-5703","authenticated-orcid":false,"given":"Daniel","family":"Palmer","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1865-3195","authenticated-orcid":false,"given":"William","family":"Greenhalf","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Copple","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9645-6394","authenticated-orcid":false,"given":"Chris","family":"Goldring","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7012-1196","authenticated-orcid":false,"given":"Thilo","family":"Hackert","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf , Hamburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jackson","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-7399","authenticated-orcid":false,"given":"John P","family":"Neoptolemos","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University of Heidelberg , Heidelberg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-101X","authenticated-orcid":false,"given":"Christoph","family":"Springfeld","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital , Heidelberg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W","family":"B\u00fcchler","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University of Heidelberg , Heidelberg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W","family":"Michalski","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf , Hamburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ghaneh","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-8992","authenticated-orcid":false,"given":"Eithne","family":"Costello","sequence":"additional","affiliation":[{"name":"Liverpool Experimental Cancer Medicine Centre, University of Liverpool , Liverpool,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026040911344428900_djaf345-B1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026040911344428900_djaf345-B2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"2026040911344428900_djaf345-B3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"2026040911344428900_djaf345-B4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","article-title":"Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial","volume":"304","author":"Neoptolemos","year":"2010","journal-title":"JAMA"},{"key":"2026040911344428900_djaf345-B5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"2026040911344428900_djaf345-B6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"key":"2026040911344428900_djaf345-B7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/or.2023.8612","article-title":"5-Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)","volume":"50","author":"Alzahrani","year":"2023","journal-title":"Oncol Rep"},{"key":"2026040911344428900_djaf345-B8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10565-006-0156-3","article-title":"Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: a potential biomarker of early damage in the pancreas","volume":"22","author":"Lyn-Cook","year":"2006","journal-title":"Cell Biol Toxicol"},{"key":"2026040911344428900_djaf345-B9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAI.0b013e31802e91d0","article-title":"NQO1 expression in pancreatic cancer and its potential use as a biomarker","volume":"16","author":"Awadallah","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2026040911344428900_djaf345-B10","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3892\/ol.2017.5821","article-title":"Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma","volume":"13","author":"Ji","year":"2017","journal-title":"Oncol Lett"},{"key":"2026040911344428900_djaf345-B11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-3002(62)90997-6","article-title":"DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties","volume":"58","author":"Ernster","year":"1962","journal-title":"Biochim Biophys Acta"},{"key":"2026040911344428900_djaf345-B12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"2026040911344428900_djaf345-B13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"2026040911344428900_djaf345-B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(24)12836-2","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H: quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol Pharmacol"},{"key":"2026040911344428900_djaf345-B15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1995.373","article-title":"Presence of a heterozygous substitution and its relationship to DT-diaphorase activity","volume":"72","author":"Kuehl","year":"1995","journal-title":"Br J Cancer"},{"key":"2026040911344428900_djaf345-B16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"2026040911344428900_djaf345-B17","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol"},{"key":"2026040911344428900_djaf345-B18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/srep00229","article-title":"A transgenic mouse model for monitoring oxidative stress","volume":"2","author":"Oikawa","year":"2012","journal-title":"Sci Rep"},{"key":"2026040911344428900_djaf345-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026040911344428900_djaf345-B20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/jnci\/djp328","article-title":"Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes","volume":"101","author":"Saif","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026040911344428900_djaf345-B21","doi-asserted-by":"crossref","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","article-title":"ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays","volume":"9","author":"Guzman","year":"2014","journal-title":"PLoS One"},{"key":"2026040911344428900_djaf345-B22","doi-asserted-by":"crossref","first-page":"e1009732","DOI":"10.1371\/journal.pgen.1009732","article-title":"High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs","volume":"17","author":"Akhtari","year":"2021","journal-title":"PLoS Genet"},{"key":"2026040911344428900_djaf345-B23","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.18632\/oncotarget.15852","article-title":"Mitochondrial \"power\" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer","volume":"8","author":"Fiorillo","year":"2017","journal-title":"Oncotarget"},{"key":"2026040911344428900_djaf345-B24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00384-011-1396-0","article-title":"Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis","volume":"27","author":"Ding","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"2026040911344428900_djaf345-B25","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.7314\/APJCP.2012.13.12.6343","article-title":"The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects","volume":"13","author":"Guo","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026040911344428900_djaf345-B26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/01635581.2018.1460674","article-title":"NQO1 gene C609T polymorphism (dbSNP: rs1800566) and digestive tract cancer risk: a meta-analysis","volume":"70","author":"Yadav","year":"2018","journal-title":"Nutr Cancer"},{"key":"2026040911344428900_djaf345-B27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12957-019-1732-3","article-title":"Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data","volume":"17","author":"Chikhladze","year":"2019","journal-title":"World J Surg Oncol"},{"key":"2026040911344428900_djaf345-B28","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/s41598-017-16491-2","article-title":"Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity","volume":"7","author":"Forootan","year":"2017","journal-title":"Sci Rep"},{"key":"2026040911344428900_djaf345-B29","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"2026040911344428900_djaf345-B30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026040911344428900_djaf345-B31","first-page":"1240","article-title":"Pancreatic adenocarcinoma: long-term outcomes of adjuvant therapy in the ESPAC4 Phase III Trial","volume":"43","author":"Palmer","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf345\/65667164\/djaf345.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/4\/643\/65667164\/djaf345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/4\/643\/65667164\/djaf345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:50:00Z","timestamp":1775749800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/4\/643\/8362232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf345","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,1]]}}}